Magnetar Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,147
| Closed | -$404K | – | 1101 |
|
|
2025
Q1 | $404K | Buy |
11,147
+4,368
| +64% | +$158K | 0.01% | 506 |
|
|
2024
Q4 | $285K | Buy |
+6,779
| New | +$285K | 0.01% | 484 |
|
|
2022
Q4 | – | Sell |
-12,583
| Closed | -$521K | – | 907 |
|
|
2022
Q3 | $521K | Buy |
+12,583
| New | +$521K | 0.01% | 813 |
|
|
2020
Q2 | – | Sell |
-11,096
| Closed | -$493K | – | 557 |
|
|
2020
Q1 | $493K | Buy |
+11,096
| New | +$493K | 0.01% | 276 |
|